During the past decade, Volgograd Regional Clinical Cardiology Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Volgograd Regional Clinical Cardiology Center" are "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "History of Myocardial Infarction" (1 trials), "Hypertriglyceridemia" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Volgograd Regional Clinical Cardiology Center" in a lesser frequency.

Most popular intervention types in "Volgograd Regional Clinical Cardiology Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Macitentan" (1 trials), "Macitentan 10 mg" (1 trials), "Macitentan 37.5 mg" (1 trials) and "Macitentan 75 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Volgograd Regional Clinical Cardiology Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Volgograd Regional Clinical Cardiology Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Volgograd Regional Clinical Cardiology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Volgograd Regional Clinical Cardiology Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".